Effects of 5-bromodeoxyuridine on tumorigenicity, immunogenicity, virus production, plasminogen activator, and melanogenesis of mouse melanoma cells.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000951:Antigens, Neoplasm; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D004156:Catechol Oxidase / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002478:Cells, Cultured / Q000166:cytology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D007700:Kinetics; D008543:Melanins / Q000096:biosynthesis*; D008545:Melanoma / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D008954:Models, Biological; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009374:Neoplasms, Experimental / Q000209:etiology*; D010858:Pigmentation / Q000187:drug effects; D010960:Plasminogen Activators / Q000378:metabolism*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D014779:Virus Replication / Q000187:drug effects*
D000951:Antigens, Neoplasm; D004273:DNA, Neoplasm; D008543:Melanins; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D004156:Catechol Oxidase; D010960:Plasminogen Activators; D001973:Bromodeoxyuridine